Driving Innovative Care
Through cutting-edge research, clinical trials, and collaborations, we focus on speeding up the development of new therapies and improving outcomes for people affected by multiple myeloma.
We identify biomarkers, evaluate new treatments, and refine clinical practices to deliver the best possible patient care.
Collaborating for Hope
We believe that by fostering partnerships and driving scientific discoveries, we can make a significant impact in the global fight against multiple myeloma.
Our goal is to offer hope to patients and their families while setting new standards in cancer care.
Key Research Areas
Our mission is to advance the understanding and treatment of multiple myeloma through cutting-edge research and clinical innovation. We are committed to translating scientific discoveries into meaningful clinical applications that improve patient outcomes and quality of life.
Below are the key research areas where we’re focusing our efforts:
Clinical Trials
Our team conducts a wide range of clinical trials focused on exploring new therapies and treatment strategies. These trials are designed to enhance the standard of care for multiple myeloma patients, offering them access to the latest advancements in medical science.
Translational
Research & Biobank
The CMRG’s translational research and biobanking program advances biomarker discovery, target validation, resistance mechanisms, and diagnostic innovation. These efforts deepen our understanding of disease biology and treatment response, enabling more precise and personalized therapies for people with multiple myeloma.
Minimal Residual Disease (MRD)
MRD detection and quantification is a crucial aspect of our research. Understanding MRD allows us to develop strategies aimed at achieving long-term remission and potentially curing multiple myeloma.
Real World Evidence (RWE)
Our research is strengthened by Real World Evidence from CMRG’s national database, helping us assess treatment outcomes in real-life settings. These insights enhance our clinical trials and deepen understanding of multiple myeloma.
Collaboration and Innovation
We work closely with leading institutions, clinicians, and researchers across the globe. Our collaborative efforts are focused on leveraging the latest technologies and methodologies to push the boundaries of myeloma research.
Patient-Centered Research
Ensuring that our research directly benefits patients is a top priority. We design our studies with the goal of improving the lives of those affected by multiple myeloma, offering hope through scientific innovation and a patient-centric approach.
Through our comprehensive research efforts, including the integration of Real-World Evidence, we aim to extend and enhance the lives of those affected by multiple myeloma, continually seeking new ways to combat this challenging disease.
Our Vision
CMRG strives to redefine the future of multiple myeloma by driving pioneering research, fostering global collaborations, and prioritizing patient-centered care. Our vision is to accelerate the discovery of transformative treatments and, ultimately, a cure for multiple myeloma.
We are dedicated to:
Innovative Research: Advancing the frontier of myeloma treatment through cutting-edge research and the development of novel therapeutic approaches.
Global Collaboration: Building strong partnerships with top research institutions and clinicians worldwide to amplify the impact of our work.
Patient-Centric Care: Ensuring that our research directly benefits patients, improving their quality of life and survival rates.
Real-World Data Integration: Leveraging Real World Evidence from our national CMRG database to inform research and enhance the relevance of our findings.
Education and Advocacy: Leading efforts to increase awareness, support education, and advocate for enhanced research funding.
Our Mission
Our mission at the Canadian Myeloma Research Group (CMRG) is to lead the charge against multiple myeloma by advancing innovative research, improving patient outcomes, and accelerating the development of new therapies.
We are committed to:
Research Excellence: Conducting groundbreaking research that deepens our understanding of multiple myeloma and leads to transformative treatments.
Patient Focus: Ensuring that our research directly translates into better care, improved quality of life, and extended survival for patients with multiple myeloma.
Collaboration: Fostering a strong network of researchers, clinicians, and industry partners to enhance the impact of our work on a global scale.
Data-Driven Approaches: Utilizing real-world evidence from our comprehensive national database to inform our research and clinical practices.
Education and Advocacy: Promoting education and awareness about multiple myeloma and advocating for policies that support research and patient care.
Through our mission, we aim to make significant strides toward a future where multiple myeloma is effectively managed and, ultimately, cured.
Our Impact
The Canadian Myeloma Research Group (CMRG) plays a vital role in advancing research, treatment, and patient care for multiple myeloma. Through pioneering studies, innovative therapies, and global collaboration, we’ve improved outcomes and helped set new standards in myeloma management. Our commitment to real-world data and patient-centred research continues to shape the future of care in Canada and beyond.
Over the past 8 years, CMRG has enrolled over 600 patients across diverse clinical trials and delivered more than 25,000 cycles of treatment. This work has generated critical real-world evidence, informed clinical practices, and led to over 30 high-impact publications in leading journals – reinforcing our position as a leader in myeloma research.
25⁺
Participating Centres
22k⁺
Cycles of Treatment to Date
27
Manuscripts Published
600⁺
Patients enrolled
50⁺
Clinicians & Researchers
12
Clinical Trials
27
Abstracts
12k⁺
strong national
clinical database
25⁺
Participating Centres
25k⁺
Cycles of MM Treatment
27
Manuscripts Published
600⁺
Patients enrolled
50⁺
Clinicians & Researchers
12
Clinical Trials
27
Abstracts
12k⁺
strong national clinical database
These numbers reflect the real impact of CMRG’s work.
Each trial, patient, and publication represents progress in advancing myeloma research across Canada. Together, they demonstrate the scope of collaboration, the lives touched through innovative treatments, and the evidence driving breakthroughs towards better care and a future cure.
CMRG Centres
Our network is made up of over 50 researchers, across 30 research centres
Meet Our Experts
At the heart of CMRG’s mission is a dedicated group of clinicians, researchers, patients, and advocates working together to drive progress in myeloma care and research.